CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(CNRS) Patent applications |
Patent application number | Title | Published |
20140346124 | REACTOR USABLE FOR DECONTAMINATION OF FLUIDS AND METHOD OF USE - The invention relates to a method for the decontamination of contaminated liquid, as well as a reactor for implementing a decontamination method. The method comprises a step of mixing the contaminated liquid under stirring with at least one persulphate ion with the exception of ammonium persulphate, and at least iron, an iron atom or an iron ion in its ferrous or ferric form at a concentration between 50 μM and 600 μM, preferably between 100 μM and 400 μM, a second step in which the mixture obtained is subjected for a sufficient time to at least one UV/visible irradiation having a narrow wavelength spectrum comprised between 153 nm and 560 nm. | 11-27-2014 |
20140148558 | ONE-STEP, ONE-POT PROCESS FOR PREPARING MULTIBLOCK AND GRADIENT COPOLYMER - The present invention relates to the field of tailored di-, tri- and multi-block as well as gradient polyesters/polycarbonates copolymers prepared by introducing monomers simultaneously in the reaction medium in the presence of an organometallic, metal salt or organic catalyst. | 05-29-2014 |
20140142325 | P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS - Novel P-chirogenic organophosphorus compounds of general formula (I), a process for the synthesis of the compounds of formula (I), and intermediate products of general formulae (II), (III) and (IV), as shown below, are involved in the synthesis of compounds (I). | 05-22-2014 |
20140121167 | THERAPEUTIC PEPTIDES AND USE THEREOF AGAINST HUNTINGTON'S DISEASE - Novel therapeutic compounds for use against Huntington's disease. More especially, an isolated peptide of size less than 100 amino acids and containing:
| 05-01-2014 |
20140083415 | SOLAR SYSTEM FOR REPRODUCING THE EFFECT OF A COMBUSTION FLAME - The present invention relates to a solar system for providing volumetric energy reproducing the effect of a combustion flame for a high-temperature industrial process, characterised in that it comprises:
| 03-27-2014 |
20130224740 | ANALYTICAL METHODS FOR CELL FREE NUCLEIC ACIDS AND APPLICATIONS - The present invention is directed to an in vitro method of detecting cell free nucleic acids, preferably cell free DNA (cfDNA) in a body fluid sample from an individual or a patient, wherein the method comprises the step of accurately and sensitively determining the concentration of cell free nucleic acid in the sample and/or determining the concentration or amount of said cell free nucleic acid of a size range and/or the index of integrity or size fraction ratio (SFR) of said cell free nucleic acid and/or the determination of the presence of genetic polymorphisms (such as known Single Nucleotide Polymorphisms (SNPs) or mutations). The invention encompasses also a method to discriminate body fluid individuals where cfDNA are highly released by comparing the size profile obtained for at least one of three size ranges of cfDNA. The invention also encompasses a method for analysing cell nucleic acids in individuals for the diagnosis, prognosis or for assessing the evolution of a physiological state, such as the progression of a tumor or metastatic cancer, for monitoring the efficacy of a cancer treatment in a patient or for theragnostic purposes implementing the analysis of these biomarkers. | 08-29-2013 |
20130102066 | CHALCOGENIDE-FIBRE, INFRARED EVANESCENT WAVE SENSOR AND PROCESS FOR PRODUCING SAME - The invention relates to a fibre sensor that enables the propagation of infrared light at at least one wavelength of 0.8 to 25 micrometres, the fibre successively comprising along its length a first infrared waveguide section ( | 04-25-2013 |
20120107319 | Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1) - The invention relates to pharmaceutical and vaccine compositions comprising an antibody binding specifically to the intracellular domain of EBV protein LMP1. | 05-03-2012 |
20120068547 | ELECTRONIC MANAGEMENT SYSTEM FOR PHOTOVOLTAIC CELLS - An electronic management system for a photovoltaic generator is disclosed herein. The, the electronic management system comprises a plurality of static microconverters, each microconverter being electrically connected to one or more photovoltaic cells, the one or more photovoltaic cells forming a portion of a whole of the cells of the generator, a reconfiguration module adapted for transmitting energy flows from said microconverters towards a load, and a central electronic unit adapted for controlling a modification of the energy flows transmitted by said at least one reconfiguration module. | 03-22-2012 |
20120062288 | Device and Method for Generating a Signal of Parametrizable Frequency - Device for generating a signal of parametrizable frequency comprising a phase locked loop including a generator of a reference signal, a phase-frequency comparator comprising a first input for receiving the reference signal, an oscillator controlled on the basis of the result output by the phase-frequency comparator, a fractional divider coupled between an output of the oscillator and a second input of the phase-frequency comparator, and a selector selectively linking an input of the oscillator either with an input of the generator, or with the output of the oscillator as a function of the multiplication ratio of the fractional divider. | 03-15-2012 |
20110117066 | ESTABLISHED HUMAN BROWN ADIPOCYTE LINE AND METHOD FOR DIFFERENTIATION FROM AN HMADS CELL LINE - The subject matter of the invention is a functional population of human brown adipocytes, in which the expression of UCP1, CIDEA, CPT1B and Bcl2 is higher, the expression of Bax is lower and the expression of PPAR-alpha, PGC-1alpha, PGC-1beta and PRDM16 is similar compared with the corresponding expressions of a population of human white adipocytes. The invention also relates to a method for differentiation of hMADS cells into the functional population of human brown adipocytes, to a method for conversion of a population of human white adipocytes into the functional population of human brown adipocytes, and also to a method of screening for molecules capable of modulating the bodyweight in an individual. | 05-19-2011 |
20110112273 | Group 3 Post-Metallocene Complexes Based on Bis(Naphthoxy)Pyridine and Bis(Naphthoxy)ThioPhene Ligands for the Ring-Opening Polymerisation of Polar Cyclic Monomers - The present invention relates to the use of group 3 post-metallocene complexes based on sterically encumbered bis(naphthoxy)pyridine and bis(naphthoxy)thiophene ligands in the ring-opening polymerisation of polar monomers such as, for examples, lactones, lactides, cyclic carbonates. | 05-12-2011 |
20110042162 | DEVICE FOR REDUCING NOISE GENERATED BY AN AIRCRAFT JET ENGINE WITH CURVE DUCTS - A jet engine, including a wall surrounding a first gas flow ejected from a downstream end of the wall along a longitudinal axis, a second flow of gas running outside the wall in a direction of ejection of the first gas flow, at least one duct arranged on the periphery of the downstream end of the wall which is desired to eject a gas flow for interacting with one and/or the other gas flow, the at least one duct including a terminal section provided at the free end thereof with an outlet opening through which the fluid is ejected. The terminal section successively includes a first section of straight duct aligned along a median axis and a second duct section forming a bend relative to the straight section, the second portion having a free end provided with the outlet opening and sufficiently close to the median axis of the first section to give the terminal section a reduced restriction in a direction of formation of the bend. | 02-24-2011 |
20110014458 | FILM HAVING WATER, GREASE, GAS AND WATER VAPOR BARRIER PROPERTIES - Film having liquid-water, grease, gas and water-vapour barrier properties, comprising a PVA film grafted on the surface with a fatty acid. | 01-20-2011 |
20110003706 | PROLIFERATION MARKERS IN CLINICAL PRACTICE AND THEIR USE FOR BREAST CANCER PROGNOSIS OR DIAGNOSIS - A method for assessing the proliferative state of cells in a human or non-human biological sample uses Chromatin Assembly Factor-1 (CAF-1) subunits as proliferation markers. The method can be used for breast cancer prognosis or diagnosis, and monitoring tumor response in therapy. | 01-06-2011 |
20100326992 | HYDROGEN STORAGE TANK - The invention relates to a tank of the type that comprises a container ( | 12-30-2010 |
20100048731 | Hydroxylated Long-Chain Resveratrol Derivatives Useful as Neurotrophic Agents - The present invention relates to a compound of general formula (I) below in which R | 02-25-2010 |
20100016631 | METHOD FOR THE SYNTHESIS OF PEPTIDES WITHOUT SOLVENT - The disclosure relates to a method for the synthesis of a compound of the formula (I) in which: n is an integer higher than or equal to 1; Rb and each Rn are independently a hydrogen atom, a C | 01-21-2010 |
20090239251 | Method for Detecting Nanoparticles and the Use Thereof - The invention relates to a method for detecting and/or qualifying nanoparticles whose mean size is less than 60 nm, which exhibit a plasmon resonance and are located on the top surface of a flat solid support. A device for carrying out the inventive method and the use thereof are also disclosed. | 09-24-2009 |